WahanaRiau.com - Aim immunotech

Berita Politik Peristiwa Ekonomi Otomotif Olahraga Teknologi Gaya Hidup Travel Video Media OutReach Globenewswire Advertorial Pilihan Editor Terpopuler Indeks

Berita
Peristiwa
Politik
Ekonomi
Teknologi
Otomotif
Olahraga
Gaya Hidup
Travel
More

Aim immunotech

Index

Globenewswire

AIM ImmunoTech Announces Final Approval of Novel Cancer Therapy Patent in Japan Combining Ampligen with Checkpoint Inhibitors

Kamis, 19 Maret 2026 - 04:13:18 Wib

Globenewswire

AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint Inhibitors

Jumat, 26 September 2025 - 00:14:53 Wib

Aim immunotech

AIM ImmunoTech Announces Final Approval of Novel Cancer Therapy Patent in Japan Combining Ampligen with Checkpoint Inhibitors

AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint Inhibitors

Terpopuler

Citi Commercial Bank Drives Dialogue on the Future of Business at Annual Executive Summit in Hong Kong
Dibaca: 166 Kali

Green SM officially launches all-electric ride-hailing service in Kazakhstan
Dibaca: 480 Kali

Thailand Launches FastPass Program, Unlocking USD 21 billion in Strategic High-Tech Investment
Dibaca: 138 Kali

OR Sets 2030 Sustainability Goals Amid Global Energy Transition, Targeting Inclusive Growth for People, Planet, and Performance
Dibaca: 162 Kali

Nervotec Launches NervoScan MCP, Giving AI Assistants a Real-World Health Signal From a 10-Second Face Scan
Dibaca: 147 Kali

Terkini

Citi Commercial Bank Drives Dialogue on the Future of Business at Annual Executive Summit in Hong Kong

Green SM officially launches all-electric ride-hailing service in Kazakhstan

Thailand Launches FastPass Program, Unlocking USD 21 billion in Strategic High-Tech Investment

OR Sets 2030 Sustainability Goals Amid Global Energy Transition, Targeting Inclusive Growth for People, Planet, and Performance

Nervotec Launches NervoScan MCP, Giving AI Assistants a Real-World Health Signal From a 10-Second Face Scan

Aim immunotech

AIM ImmunoTech Announces Final Approval of Novel Cancer Therapy Patent in Japan Combining Ampligen with Checkpoint Inhibitors

AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint Inhibitors

Terpopuler

Citi Commercial Bank Drives Dialogue on the Future of Business at Annual Executive Summit in Hong Kong Dibaca: 166 Kali

Green SM officially launches all-electric ride-hailing service in Kazakhstan Dibaca: 480 Kali

Thailand Launches FastPass Program, Unlocking USD 21 billion in Strategic High-Tech Investment Dibaca: 138 Kali

OR Sets 2030 Sustainability Goals Amid Global Energy Transition, Targeting Inclusive Growth for People, Planet, and Performance Dibaca: 162 Kali

Nervotec Launches NervoScan MCP, Giving AI Assistants a Real-World Health Signal From a 10-Second Face Scan Dibaca: 147 Kali

Terkini

Citi Commercial Bank Drives Dialogue on the Future of Business at Annual Executive Summit in Hong Kong

Green SM officially launches all-electric ride-hailing service in Kazakhstan

Thailand Launches FastPass Program, Unlocking USD 21 billion in Strategic High-Tech Investment

OR Sets 2030 Sustainability Goals Amid Global Energy Transition, Targeting Inclusive Growth for People, Planet, and Performance

Nervotec Launches NervoScan MCP, Giving AI Assistants a Real-World Health Signal From a 10-Second Face Scan

Citi Commercial Bank Drives Dialogue on the Future of Business at Annual Executive Summit in Hong Kong
Dibaca: 166 Kali

Green SM officially launches all-electric ride-hailing service in Kazakhstan
Dibaca: 480 Kali

Thailand Launches FastPass Program, Unlocking USD 21 billion in Strategic High-Tech Investment
Dibaca: 138 Kali

OR Sets 2030 Sustainability Goals Amid Global Energy Transition, Targeting Inclusive Growth for People, Planet, and Performance
Dibaca: 162 Kali

Nervotec Launches NervoScan MCP, Giving AI Assistants a Real-World Health Signal From a 10-Second Face Scan
Dibaca: 147 Kali